Press Releases Waverley Pharma Inc.

Equities

WAVE

CA94357L1058

Market Closed - Toronto S.E. Other stock markets 02:57:55 2024-06-04 pm EDT			5-day change	1st Jan Change
0.02 ^CAD	-20.00%		-20.00%	-20.00%

May. 29	Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 30	Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Waverley Pharma : Notice of meeting	May. 23	PU
Waverley Pharma : Information circular	May. 23	PU
Waverley Pharma Business Update	Apr. 30	AQ
Waverley Pharma Announces Changes to Board of Directors	Nov. 22	AQ
Waverley Pharma Business Update	23-08-02	AQ
Waverley Pharma Provides Business Update	23-03-20	AQ
Waverley Pharma Provides Update on its PARP-1 Inhibitor Program	23-01-11	AQ
Waverley Pharma : Announces $3,000,000 Credit Facility	21-08-05	AQ
Waverley Pharma : Announces Successful Tender Award for Pemetrexed with NHS England	21-05-27	AQ
Waverley Pharma : Announces Successful Tender Award for Capecitabine with NHS Scotland	21-01-18	AQ
Waverley Pharma : Announces Tentative ANDA Approval for Pemetrexed in the United States	20-11-12	AQ
Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)	20-09-23	AQ
Waverley Pharma : Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the United States	20-09-08	AQ
Waverley Pharma : Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy	20-08-25	AQ
Waverley Pharma : Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries	20-07-30	AQ
Waverley Pharma : Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Synthetic Library of Chloroquine Analogs to Treat COVID-19	20-06-25	AQ
Waverley Pharma : Announces Reliance on Relief from Filing Requirements for Annual Financial Statements	20-04-28	AQ
Waverley Pharma : Announces Appointment of New President and CEO	20-02-03	AQ
Waverley Pharma : Announces Executive Leadership Changes	20-01-08	AQ
Waverley Pharma : Announces Grant of Marketing Authorization in the United Kingdom for Erlotinib	19-12-17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Waverley Pharma Inc.

Equities

WAVE

CA94357L1058

Press Releases

Filters